ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
Sales | 5 | 7 | 0 | 0 | 0 |
Gross Profit | 5 | 7 | N/A | N/A | N/A |
Operating Expenses | 2,635 | 2,480 | 1,691 | 1,464 | 1,628 |
Operating Income | -2,630 | -2,473 | -1,691 | -1,464 | -1,628 |
Other Income | 56 | 27 | 31 | 25 | 12 |
Pre-tax Income | -2,574 | -2,445 | -1,660 | -1,439 | -1,616 |
Net Income Continuous | -2,574 | -2,445 | -1,660 | -1,439 | -1,616 |
Net Income | $-2,574 | $-2,445 | $-1,660 | $-1,439 | $-1,616 |
EPS Basic Total Ops | -5.40 | -6.12 | -3.60 | -4.32 | -6.48 |
EPS Basic Continuous Ops | -5.55 | -6.12 | -3.76 | -4.31 | -6.41 |
EPS Diluted Total Ops | -5.40 | -6.12 | -3.60 | -4.32 | -6.48 |
EPS Diluted Continuous Ops | -5.55 | -6.12 | -3.76 | -4.31 | -6.41 |
EBITDA(a) | $-2,604 | $-2,449 | $-1,668 | $-1,441 | $-1,604 |